Literature DB >> 23170147

Impaired esophageal bolus transit in patients with gastroesophageal reflux disease and abnormal esophageal Acid exposure.

Yu Kyung Cho1, Myung-Gyu Choi, Chul Hyun Lim, Jin Su Kim, Jae Myung Park, In Seok Lee, Sang Woo Kim, Kyu-Yong Choi.   

Abstract

BACKGROUND/AIMS: We assessed the bolus transit and motility characteristics in gastroesophageal reflux disease (GERD) patients with abnormal esophageal pH monitoring.
METHODS: We retrospectively reviewed the combined impedance-esophageal manometry data from consecutive patients who had abnormal acid exposure during 24-hour esophageal pH monitoring. We compared these data to the results from functional heartburn (FH) and asymptomatic volunteers.
RESULTS: The data from 33 GERD patients (mean age of 51 years, 18 males), 14 FH patients (mean age of 51 years, one male), and 20 asymptomatic volunteers (mean age of 27 years, nine males) were analyzed. Ineffective esophageal motility was diagnosed in 10% of the volunteers, 21% of the FH patients, and 15% of the GERD patients. Ineffective contraction was more frequent in GERD and FH patients than in volunteers (16% and 20% vs 6%, respectively; p<0.05). Additionally, 10% of the volunteers, 21% of the FH patients and 36% of the GERD patients had an abnormal bolus transit. Complete bolus transit was less frequent, and bolus transit was slower in GERD patients than in volunteers for liquid (70% vs 85%) and viscous swallows (57% vs 73%). A longer acid clearance time was associated with abnormal bolus transit in the GERD group.
CONCLUSIONS: Patients with GERD have mild peristaltic dysfunction and incomplete and slower esophageal bolus transit. These conditions predispose them to prolonged acid contact with the esophagus.

Entities:  

Keywords:  Bolus transit; Gastroesophageal reflux; Impedance

Year:  2012        PMID: 23170147      PMCID: PMC3493723          DOI: 10.5009/gnl.2012.6.4.440

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


INTRODUCTION

Esophageal motility disturbance has been regarded as main pathophysiologic mechanism of gastroesophageal reflux disease (GERD),1 however, manometry findings were often normal in patients with GERD. Most common pattern of peristaltic failure is ineffective esophageal motility (IEM) which is commonly associated with delayed acid clearance.2 In a subgroup of patients with nonerosive reflux disease (NERD) or mild esophagitis, acid clearance is prolonged in spite of normal or minimally impaired esophageal peristalsis.3 Several studies about esophageal bolus transit of patients with GERD have reported contradictory results.4-6 In a study with patients with reflux esophagitis, there was a marked delay in esophageal transport with increasing viscosity of the bolus. A significant delay of bolus transport in the inflamed esophageal areas was also seen.4,5 In the other esophageal impedance study with patients with mild esophagitis, overall most swallows were considered normal.6 A recent study reported abnormal bolus transit and esophageal motility abnormalities increase in parallel with the severity of GERD from NERD to erosive esophagitis and Barrett's esophagus.7 Esophageal acid clearance is composed of esophageal volume clearance, followed by chemical clearance of saliva ingestion. Combined intraluminal esophageal impedance-esophageal manometry (MII-EM) provides clinically important information about esophageal function abnormalities.8 Impedance technique to measure esophageal volume clearance was validated compared with barium emptying.3 Impedance could provide physiologically and clinically relevant information in GERD patients with abnormal acid exposure.9 Patients with abnormal acid exposure are easily supposed to have abnormal esophageal volume clearance and/or abnormal esophageal bolus transit. We aimed to evaluate the characteristics of esophageal bolus transit and motility of GERD patient with abnormal acid exposure compared with functional heartburn (FH) and normal volunteers with combined MII-EM.

MATERIALS AND METHODS

1. Asymptomatic volunteers

Twenty asymptomatic volunteers were recruited through an advertisement for other study in 2006.10 None of the subjects had gastrointestinal symptoms or a history of gastrointestinal surgery except appendectomy, and none were taking any medication. It was confirmed that no subjects had any history of cardiovascular, respiratory, neuropsychiatric, or endocrine disorders. Alcohol, smoking, and medications known to influence the gastrointestinal motility were prohibited during combined MII-EM study.

2. GERD and FH patients

The consecutive patients who had visited Seoul St. Mary's Hospital with typical or atypical GERD symptoms and underwent combined MII-EM and 24-hour esophageal pH monitoring from 2007 to 2010 were enrolled. Combined MII-EM was done prior to 24-hour esophageal pH monitoring to identify the location of lower esophageal sphincter (LES). Esophageal pH monitoring was performed by conventional or impedance monitoring. Antisecretory agents including proton pump inhibitors and medications affecting esophageal motility were discontinued within 1 week before combined MII-EM and esophageal pH monitoring. All patients underwent endoscopy. Abnormal esophageal acid exposure was defined as % time pH <4 was >4 in the 24-hour esophageal conventional or impedance pH monitoring. Among them, patients who were diagnosed to have abnormal acid exposure were classified as GERD group. Patients whose principal symptom was heartburn and esophageal pH showed normal esophageal acid exposure, negative symptom index and negative symptom association analysis were classified as FH group.

3. Esophageal function test (combined MII-EM)

The nine-channel combined MII-EM catheter (Sandhill EFT; Sandhill Scientific Inc., Highland Ranch, CO, USA) has two circumferential solid-state pressure sensors, at 5 and 10 cm from the tip, and two uni-directional pressure sensors, at 15 and 20 cm. The impedance measuring segments consist of pairs of metal rings placed 2 cm apart, centered at 10, 15, 20, and 25 cm from the tip. The catheter was inserted transnasally into the esophagus to a depth of 60 cm. The LES was identified by using a stationary pull-through technique, and the most distal part of the sensor was placed in the high-pressure zone of the LES. In the semi recumbent position, patients were administered 10 swallows of 5 mL of normal saline and 10 swallows of 5 mL of viscous (apple sauce-like consistency) material, with each swallow being taken 20 to 30 seconds apart. Normal saline was used instead of water because it has a standardized ionic concentration and provides for better impedance changes than water. Sandhill Scientific Inc. provided us with the viscous material manufactured as a food substance with a known standardized impedance value.

4. Data analysis

We reviewed the data of combined MII-EM data of GERD, FH patients, and asymptomatic volunteers. We also reviewed esophageal pH monitoring data and endoscopic results of patients group. Manometric parameters included: 1) distal esophageal amplitude as average of contraction amplitude at 5 and 10 cm above the LES, 2) mid-respiratory resting pressure, and 3) residual LES pressure during swallowing were used to assess LES function. A swallow was considered normal if contraction amplitudes at 5 and 10 cm above LES were each 30 mm Hg and distal onset velocity was <8 cm/sec. A swallow with ineffective contraction was defined if either of the contraction amplitudes at 5 and 10 cm above LES was less than 30 mm Hg, while that with simultaneous contractions was identified if contraction amplitudes at 5 and 10 cm above LES were each greater than or equal to 30 mm Hg and distal onset velocity was greater than 8 cm/sec. Subjects with 30% or more ineffective or 20% or more simultaneous contractions were considered to have abnormal esophageal manometry. MII parameters analyzed included bolus entry at each specific level obtained at the 50% point between 3 seconds pre-swallow impedance baseline and impedance nadir during bolus presence and bolus exit determined as return to this 50% point on the impedance-recovery curve. Total bolus transit time (TBTT) was calculated as time elapsed between bolus entry at 20 cm above LES and bolus exit at 5 cm above LES. Swallows were classified by MII as showing: 1) complete bolus transit, if bolus entry occurred at the most proximal site (20 cm above LES) and bolus exit points were recorded in all three distal impedance-measuring sites (i.e., 15, 10, and 5 cm above the LES); and 2) incomplete bolus transit, if bolus exit was not identified at any one of the three distal impedance-measuring sites. Using impedance criteria, normal esophageal bolus clearance can be defined as complete clearance of at least 80% of liquid boluses and at least 70% of viscous.

5. Statistical analysis

Manometric data were described by mean±standard deviation. Descriptive statistics (median, 25th to 75th percentile) were used to describe the impedance findings because they were not normally distributed. One way ANOVA test was used to assess differences in manometric and impedance parameters among the asymptomatic volunteers, FH and GERD patients in the liquid and the viscous swallows. The TBTT of swallows with incomplete bolus transit was regarded as an infinite value, and they were analyzed together with the TBTT of swallows with complete transit. For statistical significance, the alpha was set at 0.05.

RESULTS

The data of 33 patients with GERD (mean, 51±14 years old; M:F=18:15), 14 FH (mean, 51±10 years old; M:F=1:13), and 20 asymptomatic volunteers (mean, 27±6 years old; M:F=9:11) were analyzed. Body mass index was not different in the both groups. The predominant symptoms of GERD patients were heartburn (n=3), regurgitation (n=3), epigastria pain (n=4), globus (n=18), acid regurgitation+globus (n=3), Chronic cough (n=1), and voice change (n=1). Four the GERD patients had hernia from endoscopy. In accordance with the LA classification, there were three patients with grade A esophagitis and 2 patients with grade B esophagitis. Others didn't have esophageal erosion. Viscous swallow was not performed in six GERD patients and three FH patients because of absence of the viscous material. Mean percentage time of pH <4 was 7.4±3.9% in GERD group (Table 1).
Table 1

Baseline Characteristics of the GERD Group, FH Group, and Asymptomatic Volunteers

Data are presented as mean±SD or number.

GERD, gastroesophageal reflux disease; FH, functional heartburn; LA, Los Angeles classification.

1. Manometric parameters of GERD, FH, and asymptomatic volunteers

The manometric diagnoses of GERD group were normal in 25, IEM in five and nutcracker esophagus in three patients. The IEM was diagnosed in 10% of normal volunteers, 21% of FH and 15% of GERD patients (p>0.05). Mid-respiratory basal LES pressure was lowest in GERD patients and it was significantly lower in FH compared to volunteers. The distal esophageal contraction amplitude was not different among three groups (Table 2).
Table 2

Manometric Parameters and Esophageal Contraction Patterns in the GERD Group, FH Group, and Asymptomatic Volunteers

Data are presented as number (%) or mean±SD.

GERD, gastroesophageal reflux disease; FH, functional heartburn; NS, not significant; LES, lower esophageal sphincter.

*p<0.05, asymptomatic volunteers vs FH or GERD group and FH group vs GERD group; †p<0.05, asymptomatic volunteers vs FH or GERD group.

Three hundred thirty-five liquid swallows and 265 viscous swallows in GERD group, 140 liquid swallows and 110 viscous swallows in FH group and 200 liquid swallows and 197 viscous swallows in asymptomatic volunteers were analyzed. Most of liquid swallows in all groups showed normal peristaltic contraction. GERD patients showed less frequent normal peristaltic contractions in the viscous swallows, compared to FH patients and asymptomatic volunteers (5% vs 20% and 16%, p<0.05). The frequency of normal peristaltic contractions in viscous swallows was not different between other two groups.

2. Impedance parameters of GERD, FH, and asymptomatic volunteers

IEM was diagnosed in 10% of asymptomatic, 21% of FH, and 15% of GERD patients. Incomplete bolus transit was more frequent and bolus transit was slower in GERD patients than volunteers in liquid (bolus transit rate, 70% vs 85%; median TBTT, 7.1 seconds [5.7 to >12.5] vs 6.4 seconds [5.8 to 7.8]) and viscous swallows (bolus transit rate, 57% vs 73%; median TBTT, 9.6 seconds [7.4 to >12.5] vs 8.1 seconds [7.2 to >12.5]). Bolus transit rate and TBTT were not different between asymptomatic volunteers and FH patients (Table 3).
Table 3

Impedance Parameters for the GERD Group, FH Group, and Asymptomatic Volunteers

TBTT, >12.5 means 'infinite' in swallows with an incomplete bolus transit.

GERD, gastroesophageal reflux disease; FH, functional heartburn; NS, not significant; TBTT, total bolus transit time.

*p<0.05, GERD group vs asymptomatic volunteers or FH group.

3. Manometric and impedance parameters of erosive reflux disease (ERD) and NERD

The manometric and impedance data were reanalyzed according to the esophageal erosion. The basal LES pressure, distal esophageal contraction amplitude, viscous bolus transit parameters were not different in both groups (Table 4). However, TBTT in ERD group was significantly longer than NERD group in the liquid swallows (Table 5).
Table 4

Manometric Parameters for the ERD Group and NERD Groups

Data are presented as number or mean±SD.

ERD, erosive reflux disease; NERD, nonerosive reflux disease; NS, not significant; LES, lower esophageal sphincter.

Table 5

Impedance Parameters for the ERD Group and NERD Groups

TBTT, >12.5 means 'infinite' in swallows with incomplete bolus transit.

ERD, erosive reflux disease; NERD, nonerosive reflux disease; NS, not significant; TBTT, total bolus transit time.

4. Correlation between bolus transit parameters and 24-hour esophageal pH parameters

Bolus transit parameters of individual swallow were not correlated with any parameters of 24-hour pH monitoring, such as % time pH <4, DeMeester score, longest time of reflux except acid clearance time. Acid clearance time was longer in GERD patients who had abnormal bolus transit than GERD patients with normal bolus transit in liquid swallows (1.4±1.3 seconds vs 1.2±0.6 seconds, p<0.05) and viscous swallows (1.3±1.2 seconds vs 1.1±0.4 seconds, p<0.05) (Fig. 1).
Fig. 1

Acid clearance time according to bolus transit abnormality in patients with gastroesophageal reflux disease. (A) Liquid swallows. (B) Viscous swallows.

DISCUSSION

In this study, we found that patients with GERD frequently had incomplete or slow bolus transit compared to asymptomatic volunteers and FH patients. Our findings suggested that abnormal esophageal transit was a common pathophysiologic abnormality of GERD and might cause delayed esophageal volume clearance and esophageal erosions. GERD patient who had abnormal bolus transit had longer acid clearance time. These findings also suggested bolus transit abnormality would influence the prolonged acid contact. Abnormal transit underlies prolonged acid clearance by affecting esophageal emptying and saliva transport. The abnormal bolus transit was frequently observed in GERD patients 36% and 55% of in liquid and viscous swallows, respectively. As expected, patients with esophageal erosion had prolonged bolus transport. It is conceivable that the inflamed esophageal mucosa as one of the results of impaired bolus transit. The prevalence of abnormal transit in NERD patients was higher than previous studies in which demonstrated minimal transit abnormalities in NERD patients.4 This discrepancy might be related to the fact that we enrolled only patients who were confirmed as This study showed mild peristaltic dysfunction and lower LES pressure in GERD patients. Peristaltic dysfunction may be involved in impaired esophageal propulsion mechanisms and prolonged esophageal clearance.10 Mean basal LES was lowest in the GERD groups and it was lower in FH compared to volunteers, although these results were still within the normal range. Ineffective peristaltic contraction was not different in liquid swallows, but more frequent in viscous swallows in GERD group compared with other groups. Viscous swallows are more sensitive than liquid swallows to detect motor or bolus transit abnormality. In the present study, the prevalence of IEM was similar among patients with GERD, FH, and asymptomatic volunteers, the reason of that is because most of enrolled patients were NERD and other patients were mild reflux esophagitis. The esophageal motility and bolus transit patterns of FH were interesting. The esophageal bolus transit pattern of FH patients was similar as healthy volunteers, rather than GERD. However, the motility abnormality is distinct from volunteers. Mean LES pressure was lower and ineffective contraction in viscous swallows was more frequent in FH than volunteers. Their esophageal motility abnormality seems to be between asymptomatic volunteers and GERD. These results also support the exclusion of FH from real GERD with abnormal pH acid exposure. From the results of this study, abnormal transit could be as a biomarker for clinical trial in patients with GERD. Outcome data would be needed to evaluate the prognostic value of combined MII-EM in patients with GERD during therapeutic trial. Also, the results of this study suggest the therapeutic possibility of prokinetics even in GERD patients with normal manometric findings. There are some limitations in this study. First, the asymptomatic volunteers were not age, sex-matched control and were not recruited during the same study period. Strictly saying, abnormal bolus transit was also observed in the control group, although infrequently. It suggests the asymptomatic control groups might not represent true normal subject. Second, the number of patients with ERD was too small to characterize the bolus transit in these patients. However, the present study has some strength. The GERD group was homogenous. All of the patients had abnormal esophageal exposure irrespective of symptom association. In conclusion, GERD patients with abnormal acid exposure were characterized by mild peristaltic dysfunction, lower LES pressure, and delayed and frequent abnormal esophageal bolus transit. It suggests that peristaltic dysfunction and functional defects in these patients predispose them to prolonged acid contact in the esophagus.
  10 in total

1.  The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers.

Authors:  Yu Kyung Cho; Myung-Gyu Choi; Hae Won Han; Jae Myung Park; Jung Hwan Oh; Jeong Jo Jeong; Young Seok Cho; In Seok Lee; Sang Woo Kim; Kyu Yong Choi; In-Sik Chung
Journal:  J Clin Gastroenterol       Date:  2006-04       Impact factor: 3.062

2.  Characteristics of oesophageal bolus transport in patients with mild oesophagitis.

Authors:  Gerson R Domingues; Ron Winograd; Eponina M Lemme; Frank Lammert; Jiri Silny; Siegfried Matern; Huan N Nguyen
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-03       Impact factor: 2.566

Review 3.  Oesophageal intraluminal impedance can identify subtle bolus transit abnormalities in patients with mild oesophagitis.

Authors:  Daniel Sifrim; Radu Tutuian
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-03       Impact factor: 2.566

4.  Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.

Authors:  E Savarino; L Gemignani; D Pohl; P Zentilin; P Dulbecco; L Assandri; E Marabotto; D Bonfanti; S Inferrera; V Fazio; A Malesci; R Tutuian; V Savarino
Journal:  Aliment Pharmacol Ther       Date:  2011-06-14       Impact factor: 8.171

5.  Ineffective esophageal motility (IEM): the primary finding in patients with nonspecific esophageal motility disorder.

Authors:  L P Leite; B T Johnston; J Barrett; J A Castell; D O Castell
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

6.  Differences in oesophageal bolus transit between patients with and without erosive reflux disease.

Authors:  C L Chen; C H Yi; I J Cook
Journal:  Dig Liver Dis       Date:  2008-03-04       Impact factor: 4.088

7.  Esophageal peristaltic dysfunction in peptic esophagitis.

Authors:  P J Kahrilas; W J Dodds; W J Hogan; M Kern; R C Arndorfer; A Reece
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

8.  Measuring esophageal motility with a new intraluminal impedance device. First clinical results in reflux patients.

Authors:  J Fass; J Silny; J Braun; U Heindrichs; B Dreuw; V Schumpelick; G Rau
Journal:  Scand J Gastroenterol       Date:  1994-08       Impact factor: 2.423

9.  Relevance of ineffective oesophageal motility during oesophageal acid clearance.

Authors:  M Simrén; J Silny; R Holloway; J Tack; J Janssens; D Sifrim
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

Review 10.  Review article: intra-oesophageal impedance monitoring for the assessment of bolus transit and gastro-oesophageal reflux.

Authors:  J M Conchillo; A J Smout
Journal:  Aliment Pharmacol Ther       Date:  2008-10-03       Impact factor: 8.171

  10 in total
  8 in total

1.  Roles of High-resolution Manometry in Predicting Incomplete Bolus Transit in Patients With Dysphagia.

Authors:  Zhaohong Shi; Jie Guo; John Clarke; Haifeng Jin; Xinjun Wang; Nina Zhang; Ellen Stein; Sameer Dhalla; Pankaj J Pasricha; Jiande D Z Chen
Journal:  J Clin Gastroenterol       Date:  2018-10       Impact factor: 3.062

2.  Aging Effects on Esophageal Transit Time in the Upright Position During Videofluoroscopy.

Authors:  Kendrea L Focht Garand; Lindsey Culp; Bin Wang; Kate Davidson; Bonnie Martin-Harris
Journal:  Ann Otol Rhinol Laryngol       Date:  2020-01-30       Impact factor: 1.547

3.  Gastroesophageal reflux disease and chronic cough: A possible mechanism elucidated by ambulatory pH-impedance-pressure monitoring.

Authors:  Xiaoqing Li; Sihui Lin; Zhifeng Wang; Hong Zhang; Xiaohong Sun; Ji Li; Dong Wu; Meiyun Ke; Xiucai Fang
Journal:  Neurogastroenterol Motil       Date:  2019-09-03       Impact factor: 3.598

4.  The level of impaired esophageal bolus transit measured by multichannel intraluminal impedance: Cross-sectional study.

Authors:  Faiz Tuma; Jafar Aljazeeri; Zhamak Khorgami; Leena Khaitan
Journal:  Ann Med Surg (Lond)       Date:  2021-04-19

5.  Abnormal sensory perception or peristaltic dysfunction: which one is associated with symptoms?

Authors:  Jung Ho Park
Journal:  J Neurogastroenterol Motil       Date:  2014-07-31       Impact factor: 4.924

6.  Esophageal Body Motility for Clinical Assessment in Patients with Refractory Gastroesophageal Reflux Symptoms.

Authors:  Liuqin Jiang; Bixing Ye; Ying Wang; Meifeng Wang; Lin Lin
Journal:  J Neurogastroenterol Motil       Date:  2017-01-30       Impact factor: 4.924

7.  Validation of the Korean Version of the Gastroesophageal Reflux Disease Questionnaire for the Diagnosis of Gastroesophageal Reflux Disease.

Authors:  Eun Jeong Gong; Kee Wook Jung; Yang-Won Min; Kyoung Sup Hong; Hye-Kyung Jung; Hee Jung Son; Do Yeon Kim; Jungbok Lee; Oh Young Lee
Journal:  J Neurogastroenterol Motil       Date:  2019-01-31       Impact factor: 4.924

Review 8.  Esophageal Motor Dysfunctions in Gastroesophageal Reflux Disease and Therapeutic Perspectives.

Authors:  Sihui Lin; Hua Li; Xiucai Fang
Journal:  J Neurogastroenterol Motil       Date:  2019-10-30       Impact factor: 4.924

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.